SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is a top trending topic as market manipulation allegations, including a reported exchange error and institutional reallocations, intensify community debate over its fundamental value and perceived role in illicit transactions like ransom payments.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending following the successful unfurling of its BlueBird 6 satellite and recent FCC approval for US beta testing with AT&T and Verizon, validating its direct-to-device technology. This major de-risking event is driving strong community excitement and institutional accumulation, with discussions now focused on imminent commercial rollouts and further satellite deployments.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending as the Dow Jones Industrial Average ETF surges past the 50,000 milestone to new all-time highs, sparking debate between celebratory bulls and skeptical bears who warn of an overextended market. This rally is seen by some as a rotation into industrials away from recent tech volatility, amidst broader market uncertainty.

Mattel, Inc. engages in the ownership of children's and family entertainment franchises. It operates through the following segments: North America, International, and American Girl. The North America and International segments focus on marketing and selling toys and consumer products. The American Girl segment includes marketing, retailing, and publishing dedicated to its mission to help girls grow up with confidence and character. The company was founded by Elliot Handler, Ruth Handler, and Harold Matson in 1945 and is headquartered in El Segundo, CA.

Mattel, Inc.

Mattel is trending following a substantial drop in share price after disappointing recent holiday quarter earnings and a soft outlook. Community discussion centers on whether the market's reaction is overdone, creating a "buy the dip" opportunity, especially given the announced $1.5 billion share buyback and the company's pivot into digital gaming.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to a sharp stock decline following its earnings report, where a revenue miss attributed to softening crypto trading is sparking intense debate among investors, despite record growth in Gold subscribers and emerging prediction markets.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as its latest financial disclosures, despite EV-related losses, highlighted a significant revenue beat and an optimistic 2026 profitability guidance, driven by cost reductions and product mix. The community is focused on this forward-looking strategy and management's pivot toward high-margin vehicles and hybrids amidst ongoing debates about tariffs and market dynamics.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as the broader wealth management sector reacts to fears that new AI-powered tax planning tools, like Altruist's Hazel, will disrupt traditional advisory models and compress margins, though many in the community view the sell-off as an overreaction and a buying opportunity.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi is trending due to a significant sell-off following the termination of a construction funding agreement with a key prospective tenant for its large-scale AI data center project. The community is sharply divided, with many debating if this is an overreaction and a buying opportunity given the high demand for power in the AI sector, or if it signals deeper issues for the pre-revenue company also facing a class-action lawsuit.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF ($CHPY) is trending as investors are actively discussing its consistent weekly dividends and impressive NAV stability, distinguishing it from many other high-yield income funds. The community frequently highlights its strategic exposure to top semiconductor and AI stocks as a key factor in its strong performance for income-focused portfolios.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is trending following its earnings report, which highlighted robust revenue and loan origination growth alongside a positive future outlook and a leadership transition to a new CEO. Community sentiment is mixed, with some celebrating resilience in the fintech sector while others express skepticism over an EPS miss and macro concerns impacting consumer lending, contributing to a volatile market reaction.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Evommune stated that it designed the Phase 2a trial to evaluate the safety and efficacy of an intravenous 5 milligram per kilogram dose of EVO301 over 12 weeks.</li><li>The company said it had 70 patients in the trial, and EVO301 achieved a 33% placebo-adjusted improvement in the Eczema Area and Severity Index at week 12.</li><li>Evommune said EVO301 showed a favorable safety profile with no serious adverse events reported.</li></ul>Evommune Inc. (EVMN) shares nearly doubled in value in Tuesday’s pre-market trade before paring some of the gains to hover 50% higher in the opening trade after the company reported positive results from its atopic dermatitis trial.Evommune stated that its atopic dermatitis treatment, EVO301, met its primary endpoint at week 12 during the&nbsp;mid-stage trial. The company said that EVO301 achieved highly statistically significant outcomes in adult patients with moderate-to-severe atopic dermatitis.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/EVMN">Evommune</a> trended in the ‘neutral’ territory at the time of writing. The EVMN stock was among the top five trending tickers on the platform.<h2 class="st-heading-2">Evommune Details Results Of The Trial</h2>Evommune stated that it designed the Phase 2a trial to evaluate the safety and efficacy of an intravenous 5 milligram per kilogram dose of EVO301 over 12 weeks.“These data support our plans to move EVO301 into a Phase 2b dose-ranging trial where we can optimize the dose and seek to further improve patient outcomes,” said Evommune President and CEO, Luis Peña.The company said it had 70 patients in the trial, and EVO301 achieved a 33% placebo-adjusted improvement in the Eczema Area and Severity Index (EASI) at week 12.Evommune said EVO301 showed a favorable safety profile, with no serious adverse events reported and no treatment-related discontinuations due to adverse events.Dr. Mark G. Lebwohl, Dean for Clinical Therapeutics and Chairman Emeritus of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai, stated that EVO301’s ability to target the interleukin-18 (IL-18) mechanism and demonstrate clinically relevant activity could present patients with “real benefits.”<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>One bullish user stated that there has been “only good news” with the Evommune stock so far.<stembedurl>https://stocktwits.com/swingingg/message/644564885</stembedurl>Another user stated that the IL-18, a known inflammatory pathway which plays a key role in various immune processes, is “working great” for dermatitis.<stembedurl>https://stocktwits.com/JanetBSmellin/message/644548490</stembedurl><a href="https://stocktwits.com/symbol/EVMN">EVMN stock</a> is up 45% year-to-date and 44% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/michael-saylor-bitcoin-volatility-bug-as-well-as-feature/cZbUI8AR4Yx">Michael Saylor Calls Bitcoin Volatility Both A Bug And A Feature, Touts It As ‘Digital Capital’: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

This Biotech Stock Nearly Doubled In Value Today Morning – What’s Driving Investor Optimism?

The company said that EVO301 achieved highly statistically significant outcomes in adult patients with moderate-to-severe atopic dermatitis.

Equity

Evommune (NYSE:EVMN) Stock Price Down 5.3% - Time to Sell?

Evommune (NYSE:EVMN) Shares Down 5.3% - Here's What Happened...

Evommune (NYSE:EVMN) Trading 10% Higher - What's Next?

Evommune (NYSE:EVMN) Stock Price Up 10% - Time to Buy...

Evommune (NYSE:EVMN) Now Covered by Oppenheimer

Oppenheimer initiated coverage on Evommune in a research report on Thursday. They set an "outperform" rating and a $42.00 price objective on the stock...

Evommune (NYSE:EVMN) Stock Price Up 7.7% - Still a Buy?

Evommune (NYSE:EVMN) Trading 7.7% Higher - Still a Buy...

Evommune, Inc. (NYSE:EVMN) Given Consensus Recommendation of "Buy" by Analysts

Shares of Evommune, Inc. (NYSE:EVMN - Get Free Report) have been assigned an average recommendation of "Buy" from the ten analysts that are currently covering the firm, Marketbeat Ratings reports...

Evommune (NYSE:EVMN) Trading Down 7.7% - Here's What Happened

Evommune (NYSE:EVMN) Stock Price Down 7.7% - Should You Sell...

Evommune (NYSE:EVMN) Shares Gap Up - What's Next?

Evommune (NYSE:EVMN) Shares Gap Up - Here's Why...

Evommune (NYSE:EVMN) Trading 5.3% Higher - Time to Buy?

Evommune (NYSE:EVMN) Trading Up 5.3% - Here's Why...

Evommune, Inc. (NYSE:EVMN) Given Consensus Rating of "Buy" by Brokerages

Shares of Evommune, Inc. (NYSE:EVMN - Get Free Report) have received an average recommendation of "Buy" from the seven brokerages that are currently covering the stock, MarketBeat reports. One...

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

Stocktwits

Shopify Inc

Stocktwits Polls

Evommune Inc

The stock is surging after positive Phase 2a clinical trial results for its eczema drug, EVO301, met primary endpoints with robust efficacy.

Analysts are rapidly raising price targets, with some firms like H.C. Wainwright increasing to $65 and Evercore ISI to $55, driven by the strong clinical data.

Traders are keenly watching for a potential short squeeze as the price rises significantly, trapping bearish bets and fueling further upward movement.

High volatility and wide price ranges throughout the day are creating ample scalping and day trading opportunities for short-term momentum traders.

EVMN's sharp rise is contributing to a noticeable buzz across the biotech sector, drawing attention to other companies with clinical trial news.

Current Price	$29.03
Prev Close	$16.99
Open	$29.52
Dividend Yield	N/A
50-Day Moving Average	$18.62
Beta	0.00
Avg. Volume	366,940.50
PE Ratio	N/A

52-Week High	$24.03
52-Week Low	$13.89
Market Capitalization	$535.59M
EPS (Annual)	-$2.27
Price to Book	-2.92
Revenue Per Employee	$170,731.71

EVMN
Evommune Inc

Feed

News

Sentiment

Fundamentals

Info

Latest EVMN News

EVMNEvommune Inc